Biotech

All Articles

Arch finalizes $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund from Bain Funds Life Sciences, Arch Venture Allies is confirming ...

Orion to use Aitia's 'digital doubles' to find brand new cancer medicines

.Finnish biotech Orion has actually spied possible in Aitia's "electronic double" technician to buil...

Windtree's surprise med rears high blood pressure in most current period 2 win

.While Windtree Therapies has battled to develop the financial origins needed to have to make it thr...

2 cancer biotechs merge, producing global impact

.OncoC4 is taking AcroImmune-- and its internal scientific production capacities-- under its wing in...

Amgen records first period 3 win for $400M eczema drug

.Amgen has actually shared (PDF) the first stage 3 records on its $400 million chronic eczema drug, ...

Biogen, UCB file period 3 lupus gain after stopping working earlier test

.Biogen as well as UCB's gamble on developing right into phase 3 on the back of a broken research st...

Aptadir wishes brand-new RNA inhibitors may turn around complicated cancers

.Italian biotech Aptadir Therapeutics has actually released with the assurance that its pipeline of ...

Wave surfs DMD effectiveness to regulators' doors, sending out stockpile

.Surge Lifestyle Sciences has met its own goal in a Duchenne muscle dystrophy (DMD) study, installin...

Sanofi picks new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold, occupy...

Achilles droplets tissue therapy course, braces for cutbacks after overlooking 'industrial feasibility' objectives

.Achilles Rehabs has actually shreded its own technique. The English biotech is actually quiting wor...